Quantitative Investment Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,868
Closed -$8.92M 749
2017
Q4
$8.92M Sell
3,868
-4,338
-53% -$8.81M 0.13% 172
2017
Q3
$14.6M Buy
8,206
+115
+1% +$161K 0.17% 158
2017
Q2
$11M Buy
8,091
+7,466
+1,195% +$9.01M 0.17% 151
2017
Q1
$736K Buy
+625
New +$638K 0.01% 585
2016
Q4
Sell
-3,605
Closed -$3.17M 796
2016
Q3
$3.17M Buy
+3,605
New +$2.61M 0.1% 232
2015
Q3
Sell
-2,061
Closed -$4.5M 685
2015
Q2
$4.5M Buy
2,061
+1,343
+187% +$2.74M 0.68% 27
2015
Q1
$1.12M Buy
+718
New +$947K 0.11% 181

Other funds holding BLUE

Quantitative Investment Management's BLUE Position: Q1 2018 in Review

Quantitative Investment Management sold out of bluebird bio (BLUE) in Q1 2018, closing a stake of 3,868 shares — an estimated $8.92M sold.

Quantitative Investment Management first reported a position in BLUE in Q1 2015 and held it in 7 quarters. The position peaked at $14.6M in Q3 2017. 303 funds tracked by Wall St. Rank hold BLUE as of Q1 2018.

  • Quantitative Investment Management reported no remaining bluebird bio position as of Q1 2018 after selling out during the quarter.
  • Quantitative Investment Management sold 3,868 bluebird bio shares in Q1 2018, an estimated $8.92M.
  • Quantitative Investment Management first reported a position in bluebird bio in Q1 2015 and held it in 7 quarters.
  • Quantitative Investment Management's bluebird bio position peaked at $14.6M in Q3 2017.
  • 303 funds tracked by Wall St. Rank held bluebird bio as of Q1 2018.

Based on Quantitative Investment Management's 13F filing for Q1 2018, filed 15 May 2018.